Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: Case studies of tumor region-of-interest changes

Radiology

Volumn 252, Issue 2, 2009, Pages 551-560

  Jiang, Shudong ^a   Pogue, Brian W ^a   Carpenter, Colin M ^a   Poplack, Steven P ^b   Wells, Wendy A ^b   Kogel, Christine A ^b   Forero, Jorge A ^b   Muffly, Lori S ^b   Schwartz, Gary N ^b   Paulsen, Keith D ^a   Kaufman, Peter A ^b  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; GADODIAMIDE; PACLITAXEL; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; PRIORITY JOURNAL; TOMOGRAPHIC DIFFUSE OPTICAL SPECTROSCOPY; TOMOGRAPHY; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; AGED; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; OPTICAL TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTOMETRY; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MIDDLE AGED; NEOADJUVANT THERAPY; NEPHELOMETRY AND TURBIDIMETRY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS; TOMOGRAPHY, OPTICAL; TREATMENT OUTCOME;

EID: 70249087329     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2522081202     Document Type: Article

References (32)

1. Esteva FJ, Hortobagyi GN. Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer? [comment] J Natl Cancer Inst 2008;100:521-523.
2. Chollet P, Abrial C, Durando X, et al. A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN). Cancer J 2008;14:128-132.
3. von Minckwitz G. Preoperative therapy: what, when and for whom? Ann Oncol 2008;19(suppl 5):v113-v116.
4. Tordai A, Wang J, Andre F, et al. Evaluation of biological pathways involved in chemotherapy response in breast cancer. Breast Cancer Res 2008;10:R37. (Pubitemid 351697597)
5. Huber S, Medl M, Helbich T, et al. Locally advanced breast carcinoma: computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress). J Ultrasound Med 2000;19:601-607. (Pubitemid 30778350)
6. Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005;184:1774-1781. (Pubitemid 40770147)
7. Manton DJ, Chaturvedi A, Hubbard A, et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006;94:427-435. (Pubitemid 43237566)
8. Dunnwald LK, Gralow JR, Ellis GK, et al. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Cancer 2005;103:680-688.
9. Cerussi A, Hsiang D, Shah N, et al. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 2007;104:4014-4019. (Pubitemid 47181570)
10. Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy - a pilot study at 4 T. Radiology 2004;233:424-431.
11. Tripathy D, Jiang L, Rao N, et al. Blood oxygen level dependent (BOLD) contrast MRI and breast cancer chemotherapy response [abstr no. 10514]. In: Proceedings of the 42nd annual meeting of the American Society of Clinical Oncology 2006, Chicago, Ill, June 2-6, 2006; 569S.
12. Rousseau C, Devillers A, Sagan C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F] fluorodeoxyglucose positron emission tomography. J Clin Oncol 2006;24:5366-5372. (Pubitemid 46623167)
13. Contrast-enhanced breast MRI and MRS for evaluation of patients undergoing neoadjuvant treatment for locally advanced breast cancer. American College of Radiology Imaging Network. ACRIN protocol 6657. http://www.acrin.org/ 6657-protocol.aspx. Accessed April 7, 2008.
14. Srinivasan S, Pogue BW, Jiang S, et al. In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction. Acad Radiol 2006;13:195-202.
15. Ntziachristos V, Chance B. Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res 2001;3:41-46. (Pubitemid 32223652)
16. Franceschini MA, Moesta KT, Fantini S, et al. Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci U S A 1997;94:6468-6473. (Pubitemid 27270708)
17. Tromberg BJ, Shah N, Lanning R, et al. Noninvasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000;2:26-40. (Pubitemid 30123178)
18. Wang X, Pogue BW, Jiang S, et al. Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with nearinfrared tomography. J Biomed Opt 2006;11:041106. (Pubitemid 44803728)
19. Bartek M, Wang X, Wells W, Paulsen KD, Pogue BW. Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue. J Biomed Opt 2006;11:064007. (Pubitemid 46323010)
20. Wells WA, Wang X, Paulsen KD, Pogue BW. Phase contrast microscopy analysis of breast tissues: differences in benign versus malignant epithelium and stroma. Anal Quant Cytol Histol (in press).
21. Patterson MS, Wilson BC. Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt 1989;28:2331-2336.
22. Jiang S, Pogue BW, McBride TO, Doyley MM, Poplack SP, Paulsen KD. Near-infrared breast tomography calibration with optoelastic tissue simulating phantoms. J Electron Imaging 2003;12:613-620.
23. Jiang S, Pogue BW, McBride TO, Paulsen KD. Quantitative analysis of near-infrared tomography: sensitivity to the tissue-simulating precalibration phantom. J Biomed Opt 2003;8:308-315.
24. Srinivasan S, Pogue BW, Jiang S, et al. Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured by near-infrared tomography of normal breast in vivo. Proc Natl Acad Sci U S A 2003;100:12349-12354. (Pubitemid 37271563)
25. Poplack SP, Paulsen KD, Hartov A, et al. Electromagnetic breast imaging: pilot results in women with abnormal mammography. Radiology 2007;243:350-359. (Pubitemid 46649689)
26. Huber S, Medl M, Vesely M, Czembirek H, Zuna I, Delorme S. Ultrasonographic tissue characterization in monitoring tumor response to neoadjuvant chemotherapy in locally advanced breast cancer (work in progress). J Ultrasound Med 2000;19:677-686. (Pubitemid 30778339)
27. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005;91:1-10. (Pubitemid 40684933)
28. Madhu B, Watertony JC, Griffiths JR, Ryanz AJ, Robinson SP. The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy. Neoplasia 2006;8:560-567. (Pubitemid 44061311)
29. Choe R, Corlu A, Lee K, et al. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005;32:1128-1139. (Pubitemid 40586797)
30. Fiorentino C, Berruit A, Bottini A, et al. Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat 2001;69:143-151. (Pubitemid 33079021)
31. Herrada J, Iyer R, Atkinson E, et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1997;3:1565-1569. (Pubitemid 27431564)
32. Tromberg BJ, Cerussi A, Shah N, et al. Imaging in breast cancer: diffuse optics in breast cancer - detecting tumors in premenopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 2005;7:279-285. (Pubitemid 41830168)